Skip to main content
. 2017 Jul 27;8(56):95116–95134. doi: 10.18632/oncotarget.19618

Figure 10. Abemaciclib causes tumor regression as monotherapy and in combination with sunitinib.

Figure 10

Tumors were established in mice and each cohort treated as labelled. Response to therapy was determined by measurement of tumor size using calipers.